The SKIP (Supporting Kids with Diabetes in Physical Activity) study aims to identify whether a website developed for 9-12 year olds diagnosed with Type 1 Diabetes Mellitus (T1DM) could help to improve knowledge of the condition, self-efficacy to monitor and control the condition and increase their level of physical activity. The website (STAK-D) has been developed by the research team and combines educational (activity diary, diabetes-specific advice, physical activity guidance, safety information), behavioural (daily physical activities) and cognitive-behavioural (daily physical activity monitoring and goal-setting) strategies. This project is led by Dr Holly Blake (Associate Professor of Behavioural Science) based in the University of Nottingham’s School of Health Sciences. Within MindTech, Professor Cris Glazebrook (Children and Young People theme lead) and Dr Bethan Davies (Research Fellow) have been involved with the design and running of SKIP.

Children with T1DM favour web-based information and are comfortable with using electronic media, and such resources have been shown to be feasible, acceptable and effective at promoting physical activity in school-aged children. At an age when children are likely to start becoming more independent as they move towards adolescence, a dedicated, theory-based and interactive resource offers the opportunity to assist them in leading an active lifestyle while dealing with their condition.

SKIP is a feasibility trial running at Nottingham University Hospital (NUH) and University Hospitals Leicester (UHL), funded by the NIHR. It aims to recruit 50 young people (25 from each site) between September 2016 and August 2017 and follow them for six months. 25 participants will be randomly selected to have access to the website and a physical activity watch for the duration of these six months. Recruitment processes, use of the website and use of the activity watch will be examined. At the end of the trial, participants will be interviewed to understand perceptions of the website, including likes and dislikes, suggested improvements and any technical problems encountered. From this study, elements which worked well and those which require further adaptation will be uncovered to inform a larger clinical trial.

For more information about SKIP, please contact Dr Emily Knox (Research Fellow)

Related publication - STAK-D online intervention study protocol:

STAK D logo